Taiwan FDA registration 964de6c8fd9953579e8e966c0fdc7837

Hemochron Jr. Activated Partial Thromboplastin Time

TW: 漢莫克活化部分凝血酶時間試驗

Taiwan·Risk Class 2·MD·Accriva Diagnostics Inc.·Registered Aug 02, 2013 – Aug 02, 2028Active

Registration details

Analysis ID: 964de6c8fd9953579e8e966c0fdc7837
License Form: Ministry of Health Medical Device Import No. 025254
Customs Code: DHA05602525408

Company information

Manufacturer: Accriva Diagnostics Inc.
Manufacturer Country: United States
Authorized Representative: Werfen Taiwan Limited

Product details

Intended Use: The time to determine the clotting time of the activated part of the whole blood is used with the HEMOCHRON Jr. Signature or HEMOCHRON Jr. II instrument.
Product Type (Level 1): B Hematology and pathology devices
Product Type (Level 2): B7925 Partial coagulation time test
Import Information: Imported from abroad

Dates and status

Registration Date: Aug 02, 2013
Expiry Date: Aug 02, 2028

About this record

Access comprehensive regulatory information for Hemochron Jr. Activated Partial Thromboplastin Time in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 964de6c8fd9953579e8e966c0fdc7837 and manufactured by Accriva Diagnostics Inc.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.